These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 26062625)

  • 1. The preclinical stage of spinocerebellar ataxias.
    Maas RP; van Gaalen J; Klockgether T; van de Warrenburg BP
    Neurology; 2015 Jul; 85(1):96-103. PubMed ID: 26062625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Individual changes in preclinical spinocerebellar ataxia identified via increased motor complexity.
    Ilg W; Fleszar Z; Schatton C; Hengel H; Harmuth F; Bauer P; Timmann D; Giese M; Schöls L; Synofzik M
    Mov Disord; 2016 Dec; 31(12):1891-1900. PubMed ID: 27782309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis.
    Schöls L; Bauer P; Schmidt T; Schulte T; Riess O
    Lancet Neurol; 2004 May; 3(5):291-304. PubMed ID: 15099544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spinocerebellar ataxias.
    Teive HA
    Arq Neuropsiquiatr; 2009 Dec; 67(4):1133-42. PubMed ID: 20069236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depression and clinical progression in spinocerebellar ataxias.
    Lo RY; Figueroa KP; Pulst SM; Perlman S; Wilmot G; Gomez C; Schmahmann J; Paulson H; Shakkottai VG; Ying S; Zesiewicz T; Bushara K; Geschwind M; Xia G; Yu JT; Lee LE; Ashizawa T; Subramony SH; Kuo SH
    Parkinsonism Relat Disord; 2016 Jan; 22():87-92. PubMed ID: 26644294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Autosomal dominant spinocerebellar ataxia].
    Milewska D; Hoffman-Zacharska D; Zaremba J
    Neurol Neurochir Pol; 1999; 33(3):633-43. PubMed ID: 10540724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal eyeblink conditioning is an early marker of cerebellar dysfunction in preclinical SCA3 mutation carriers.
    van Gaalen J; Maas RPPWM; Ippel EF; Elting MW; van Spaendonck-Zwarts KY; Vermeer S; Verschuuren-Bemelmans C; Timmann D; van de Warrenburg BP
    Exp Brain Res; 2019 Feb; 237(2):427-433. PubMed ID: 30430184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression markers of Spinocerebellar ataxia 2. A twenty years neurophysiological follow up study.
    Velázquez-Perez L; Rodríguez-Labrada R; Canales-Ochoa N; Sanchez-Cruz G; Fernandez-Ruiz J; Montero JM; Aguilera-Rodríguez R; Diaz R; Almaguer-Mederos LE; Truitz AP
    J Neurol Sci; 2010 Mar; 290(1-2):22-6. PubMed ID: 20070987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spinocerebellar ataxia type 6.
    Solodkin A; Gomez CM
    Handb Clin Neurol; 2012; 103():461-73. PubMed ID: 21827907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spinocerebellar ataxia type 23 (SCA23): a review.
    Wu F; Wang X; Li X; Teng H; Tian T; Bai J
    J Neurol; 2021 Dec; 268(12):4630-4645. PubMed ID: 33175256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring disease progression in spinocerebellar ataxias: implications for treatment and clinical research.
    Sarro L; Nanetti L; Castaldo A; Mariotti C
    Expert Rev Neurother; 2017 Sep; 17(9):919-931. PubMed ID: 28805093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spinocerebellar ataxias (SCAs) caused by common mutations.
    Müller U
    Neurogenetics; 2021 Oct; 22(4):235-250. PubMed ID: 34401960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain pathology of spinocerebellar ataxias.
    Seidel K; Siswanto S; Brunt ER; den Dunnen W; Korf HW; Rüb U
    Acta Neuropathol; 2012 Jul; 124(1):1-21. PubMed ID: 22684686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spinocerebellar ataxia type 15: diagnostic assessment, frequency, and phenotypic features.
    Synofzik M; Beetz C; Bauer C; Bonin M; Sanchez-Ferrero E; Schmitz-Hübsch T; Wüllner U; Nägele T; Riess O; Schöls L; Bauer P
    J Med Genet; 2011 Jun; 48(6):407-12. PubMed ID: 21367767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expanding the clinical phenotype associated with ELOVL4 mutation: study of a large French-Canadian family with autosomal dominant spinocerebellar ataxia and erythrokeratodermia.
    Cadieux-Dion M; Turcotte-Gauthier M; Noreau A; Martin C; Meloche C; Gravel M; Drouin CA; Rouleau GA; Nguyen DK; Cossette P
    JAMA Neurol; 2014 Apr; 71(4):470-5. PubMed ID: 24566826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visualization, quantification and correlation of brain atrophy with clinical symptoms in spinocerebellar ataxia types 1, 3 and 6.
    Schulz JB; Borkert J; Wolf S; Schmitz-Hübsch T; Rakowicz M; Mariotti C; Schöls L; Timmann D; van de Warrenburg B; Dürr A; Pandolfo M; Kang JS; Mandly AG; Nägele T; Grisoli M; Boguslawska R; Bauer P; Klockgether T; Hauser TK
    Neuroimage; 2010 Jan; 49(1):158-68. PubMed ID: 19631275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Friedreich ataxia--diagnosis after a decade. Differential diagnosis of inherited spinocerebellar ataxias].
    Vitaszil E; Jelencsik I; Szirmai I
    Ideggyogy Sz; 2002 Nov; 55(11-12):382-93. PubMed ID: 12632799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical neurogenetics: autosomal dominant spinocerebellar ataxia.
    Shakkottai VG; Fogel BL
    Neurol Clin; 2013 Nov; 31(4):987-1007. PubMed ID: 24176420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Movement disorders in spinocerebellar ataxias.
    van Gaalen J; Giunti P; van de Warrenburg BP
    Mov Disord; 2011 Apr; 26(5):792-800. PubMed ID: 21370272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency analysis and clinical characterization of spinocerebellar ataxia types 1, 2, 3, 6, and 7 in Korean patients.
    Lee WY; Jin DK; Oh MR; Lee JE; Song SM; Lee EA; Kim GM; Chung JS; Lee KH
    Arch Neurol; 2003 Jun; 60(6):858-63. PubMed ID: 12810491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.